rs12722 — COL5A1 C/T 3'UTR
Collagen fibril assembly variant linked to soft tissue injury risk and tendon flexibility
Details
- Gene
- COL5A1
- Chromosome
- 9
- Risk allele
- T
- Consequence
- Regulatory
- Inheritance
- Codominant
- Clinical
- Risk Factor
- Evidence
- Moderate
- Chip coverage
- v3 v4 v5
Population Frequency
Ancestry Frequencies
Category
Fitness & BodyCOL5A1 — The Collagen Blueprint Behind Tendon Strength
Your tendons and ligaments are built from collagen fibrils — rope-like protein structures
that give connective tissue its strength and elasticity. Type V collagen, encoded by the
COL5A1 gene, acts as a master regulator of this construction process. It controls how thick
individual collagen fibrils11 collagen fibrils
microscopic protein cables that bundle together to form
tendons, ligaments, and other connective tissues grow by embedding within larger type I
collagen fibrils and limiting their lateral expansion. The rs12722 variant sits in the
3'UTR22 3'UTR
the 3' untranslated region of mRNA, which regulates how stable the mRNA molecule
is and how much protein gets made from it of COL5A1, where it alters how much type V
collagen your cells produce.
The Mechanism
The C-to-T change at rs12722 affects mRNA stability rather than protein structure.
Functional studies33 Functional studies
Laguette et al. Sequence variants within the 3'-UTR of the COL5A1
gene alters mRNA stability. Matrix Biology, 2011
demonstrated that the T allele produces more stable mRNA transcripts, which leads to
increased production of the type V collagen alpha-1 chain. While more collagen might sound
beneficial, an excess of type V collagen actually disrupts the normal fibril assembly
process. The resulting fibrils may have altered diameter and spacing, changing the
mechanical properties of tendons and ligaments — making them stiffer and potentially more
prone to injury under repetitive loading.
This mechanism also helps explain why the variant influences range of motion44 range of motion
Brown et al.
The COL5A1 genotype is associated with range of motion measurements. Scand J Med Sci
Sports, 2011: individuals with the CC
genotype tend to have greater joint flexibility, while TT carriers have stiffer connective
tissue and reduced range of motion.
The Evidence
The association between rs12722 and soft tissue injuries has been examined in multiple studies and meta-analyses:
- The original discovery55 original discovery
Mokone et al. The COL5A1 gene and Achilles tendon pathology. Scand J Med Sci Sports, 2006 found that the C allele (here called A2) was significantly more common in healthy controls than in patients with chronic Achilles tendinopathy (29.8% vs 18.0%, OR 1.9). - September et al.66 September et al.
September et al. Variants within the COL5A1 gene are associated with Achilles tendinopathy in two populations. Br J Sports Med, 2009 replicated the finding in a second independent population, strengthening the evidence. - A 2018 meta-analysis of 9 studies77 2018 meta-analysis of 9 studies
Lv et al. Association between polymorphism rs12722 in COL5A1 and musculoskeletal soft tissue injuries: a systematic review and meta-analysis. Oncotarget, 2018 (1,140 cases, 1,410 controls) found TT carriers had 58% higher risk of soft tissue injuries compared to CT/CC carriers (OR 1.58, 95% CI 1.33-1.89). When broken down by injury type: tennis elbow OR 2.06, ACL injuries OR 1.53, Achilles tendon pathology OR 1.48. - The largest meta-analysis to date88 largest meta-analysis to date
Guo et al. Association of COL5A1 gene polymorphisms and musculoskeletal soft tissue injuries: a meta-analysis based on 21 observational studies. J Orthop Surg Res, 2022 (2,164 cases, 5,079 controls) confirmed the association with an allelic OR of 1.14 and homozygous (TT vs CC) OR of 1.33, driven primarily by ligament injuries in Caucasian populations.
Importantly, the association appears strongest in Caucasian populations and for ligament injuries specifically. Studies in East Asian populations have generally not found significant associations, which may reflect both the lower T allele frequency in those populations (~17% vs ~58% in Europeans) and potential gene-environment differences.
Practical Implications
The TT genotype increases injury risk under a recessive model — carrying one T allele (CT) confers only modestly elevated risk, while two copies (TT) is where the meaningful increase begins. If you carry TT, this does not mean injury is inevitable. It means your connective tissue may be less resilient to repetitive strain, and proactive measures — adequate warm-up, progressive training loads, eccentric strengthening exercises, and collagen-supportive nutrition — become more important.
The C allele appears protective for flexibility and injury resistance. CC carriers tend to have greater range of motion and lower baseline risk for tendon and ligament injuries.
Interactions
The rs12722 variant interacts with other COL5A1 polymorphisms. The nearby rs13946 variant (also in the 3'UTR) has been studied alongside rs12722, and haplotype analysis suggests their combined effect may further modulate injury risk. The rs3196378 variant in the same gene has also shown independent associations with soft tissue injury susceptibility. Additionally, variants in other collagen genes (COL1A1, COL11A1, COL11A2) may compound the effect on connective tissue properties.
Genotype Interpretations
What each possible genotype means for this variant:
Lower risk of soft tissue injuries with greater flexibility
The CC genotype produces less stable COL5A1 mRNA compared to CT or TT genotypes, resulting in lower levels of type V collagen in connective tissues. Since type V collagen acts as a limiter of fibril diameter, lower production leads to normal or slightly larger collagen fibrils, which tend to produce more compliant (flexible) tendons and ligaments.
In multiple studies, CC carriers have been the reference group with the lowest incidence of chronic Achilles tendinopathy, ACL ruptures, and other soft tissue injuries. A meta-analysis of 2,164 cases and 5,079 controls confirmed that CC carriers have significantly lower odds of musculoskeletal injury compared to TT carriers (OR 0.75, inverse of TT vs CC OR 1.33).
One copy of the collagen variant — modestly elevated injury risk
Heterozygous CT carriers produce an intermediate amount of type V collagen. The T allele generates more stable mRNA than the C allele, so CT individuals produce somewhat more type V collagen than CC carriers, but less than TT homozygotes. This leads to intermediate collagen fibril properties.
In the recessive model that best fits the data, CT carriers group with CC carriers as the lower-risk category. The 2018 meta-analysis (Lv et al.) found no significant difference between CT and CC genotypes (OR 1.24, 95% CI 0.92-1.67, P=0.15). However, the 2022 meta-analysis (Guo et al.) with a larger dataset found a modest but significant difference in a dominant model (TT+CT vs CC: OR 1.28), suggesting CT carriers do carry some elevated risk compared to CC.
Elevated risk of soft tissue injuries — proactive prevention recommended
The TT genotype leads to the most stable COL5A1 mRNA and the highest production of type V collagen. Excess type V collagen integrates into growing collagen fibrils and restricts their lateral growth, resulting in thinner, more densely packed fibrils. This altered fibril architecture makes tendons and ligaments stiffer and less compliant, reducing their ability to absorb and distribute mechanical stress.
The largest meta-analysis (Guo et al. 2022, 21 studies, 2,164 cases, 5,079 controls) confirmed that TT carriers face significantly higher odds of musculoskeletal injury (TT vs CC: OR 1.33, 95% CI 1.08-1.65). The earlier Lv et al. 2018 meta-analysis found an even stronger effect in the recessive model (OR 1.58, 95% CI 1.33-1.89). The association is driven primarily by ligament injuries and is strongest in Caucasian populations.
It is important to note that this is a risk factor, not a deterministic finding. Many TT carriers never experience tendon or ligament injuries, particularly if they train sensibly and maintain good connective tissue health. Conversely, injury prevention strategies become especially valuable for TT carriers engaged in high-impact or repetitive-loading sports.
Key References
Mokone et al. — first study linking COL5A1 BstUI RFLP to Achilles tendon pathology in South African cohort (Scand J Med Sci Sports 2006)
September et al. — COL5A1 variants associated with Achilles tendinopathy in two independent populations (Br J Sports Med 2009)
Laguette et al. — rs12722 T allele enhances mRNA stability, increasing type V collagen production and altering fibril architecture (Matrix Biol 2011)
Lv et al. — meta-analysis of 9 studies (1140 cases, 1410 controls): TT genotype OR 1.58 for soft tissue injuries in recessive model (Oncotarget 2018)
Pabalan et al. — meta-analysis of COL5A1 polymorphisms and tendon-ligament injury risk in Caucasians (Sports Med Open 2018)
Guo et al. — meta-analysis of 21 studies (2164 cases, 5079 controls): allelic OR 1.14 for musculoskeletal injuries (J Orthop Surg Res 2022)